DISCLOSURE OF TRADING IN OWN SHARES PRE-PAID FORWARD AGREEMENT ON ITS OWN SHARES
As part of the pre-paid forward agreement entered into on March 20, 20181 with Crédit Agricole Corporate and Investment Bank relating to 4,545,454 Ubisoft treasury shares, to be settled at maturity (March 22, 2021) or by anticipation, in whole or in part, at Ubisoft’s2 initiative (the “Contract“), the Company has: § on the one hand, decided on … Continue reading DISCLOSURE OF TRADING IN OWN SHARES PRE-PAID FORWARD AGREEMENT ON ITS OWN SHARES Continue Reading
Kaskela Law LLC announces that it is investigating Proteostasis Therapeutics, Inc. on behalf of the company’s shareholders. On August 24, 2020, Proteostasis announced that it had entered into a definitive merger agreement with Yumanity Therapeutics (“Yumanity”). According to the announcement, under the terms of the merger agreement PTI will acquire all outstanding shares of Yumanity in …